Mir Hashim - Jul 29, 2021 Form 3/A - Amendment Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role: Chief Scientific Officer
Signature: /s/ Josh Seidenfeld, Attorney-in-Fact for Mir Hashim
Stock symbol: RANI
Transactions as of: Jul 29, 2021
Transactions value $: $0
Form type: 3/A - Amendment
Date filed: 8/2/2021, 08:09 PM
Date Of Original Report: Jul 29, 2021
Next filing: Sep 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	RANI	Class B Common Stock						172K	Jul 29, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	RANI	Class A Common LLC Units							Jul 29, 2021	Class A Common Stock	546K		Direct	F1, F2
holding	RANI	Stock Option (Right to Buy)							Jul 29, 2021	Class A Common Stock	211K	$9.45	Direct	F1, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This amendment is being filed to correctly reflect the shares held.
F2	Represents Common LLC Units of Rani Therapeutics, LLC, a direct subsidiary of the Issuer. The Common LLC Units are redeemable at the election of the Reporting Person at any time for newly-issued Class A Common Stock of the Issuer ("Class A Shares") on a one-for-one basis or, if mutually agreed with the Issuer, a cash payment equal to the volume weighted average market price of one Class A Share for each Common LLC Unit redeemed (subject to customary adjustments, including for stock splits, stock dividends and reclassifications). However, the Issuer may elect to effect a direct exchange of such Class A Shares (or such cash, if mutually agreed) for such Common LLC Units.
F3	The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from June 17, 2021.
F4	This amendment is being filed to correctly reflect the exercise price of the Stock Option.